- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 819202, 5 pages
Glyoxal Formation and Its Role in Endogenous Oxalate Synthesis
Department of Urology, Wake Forest University Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA
Received 16 August 2011; Accepted 7 February 2012
Academic Editor: Robert E. Brannigan
Copyright © 2012 Jessica N. Lange et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. P. Holmes and D. G. Assimos, “Glyoxylate synthesis, and its modulation and influence on oxalate synthesis,” Journal of Urology, vol. 160, no. 5, pp. 1617–1624, 1998.
- J. Knight, D. G. Assimos, M. F. Callahan, and R. P. Holmes, “Metabolism of primed, constant infusions of [1,2-13C2] glycine and [1-13C1] phenylalanine to urinary oxalate,” Metabolism, vol. 60, no. 7, pp. 950–956, 2011.
- J. Knight, D. G. Assimos, L. Easter, and R. P. Holmes, “Metabolism of fructose to oxalate and glycolate,” Hormone and Metabolic Research, vol. 42, no. 12, pp. 868–873, 2010.
- J. Knight, J. Jiang, D. G. Assimos, and R. P. Holmes, “Hydroxyproline ingestion and urinary oxalate and glycolate excretion,” Kidney International, vol. 70, no. 11, pp. 1929–1934, 2006.
- E. A. Abordo, H. S. Minhas, and P. J. Thornalley, “Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity,” Biochemical Pharmacology, vol. 58, no. 4, pp. 641–648, 1999.
- N. Shangari and P. J. O'Brien, “The cytotoxic mechanism of glyoxal involves oxidative stress,” Biochemical Pharmacology, vol. 68, no. 7, pp. 1433–1442, 2004.
- P. J. Thornalley, “The glyoxalase system in health and disease,” Molecular Aspects of Medicine, vol. 14, no. 4, pp. 287–371, 1993.
- J. Kielhorn, C. Pohlenz-Michel, and S. Schmidt, Glyoxal. Concise International Chemical Assessment Document 57, World Health Organization, Geneva, Switzerland, 2004.
- P. O'Brien, A. Siraki, and N. Shangari, “Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health,” Critical Reviews in Toxicology, vol. 35, no. 7, pp. 609–662, 2005.
- P. J. Thornalley, A. Langborg, and H. S. Minhas, “Formation of glyoxal, methylglyoxal and 8-deoxyglucosone in the glycation of proteins by glucose,” Biochemical Journal, vol. 344, no. 1, pp. 109–116, 1999.
- K. J. Wells-Knecht, D. V. Zyzak, J. E. Litchfield, S. R. Thorpe, and J. W. Baynes, “Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose,” Biochemistry, vol. 34, no. 11, pp. 3702–3709, 1995.
- P. Manini, P. La Pietra, L. Panzella, A. Napolitano, and M. d'Ischia, “Glyoxal formation by Fenton-induced degradation of carbohydrates and related compounds,” Carbohydrate Research, vol. 341, no. 11, pp. 1828–1833, 2006.
- T. Hofmann, W. Bors, and K. Stettmaier, “Studies on radical intermediates in the early stage of the nonenzymatic browning reaction of carbohydrates and amino acids,” Journal of Agricultural and Food Chemistry, vol. 47, no. 2, pp. 379–390, 1999.
- N. Shangari, F. Depeint, R. Furrer et al., “A thermolyzed diet increases oxidative stress, plasma α-aldehydes and colonic inflammation in the rat,” Chemico-Biological Interactions, vol. 169, no. 2, pp. 100–109, 2007.
- H. Yin and N. A. Porter, “New insights regarding the autoxidation of polyunsaturated fatty acids,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 170–184, 2005.
- G. Spiteller, W. Kern, and P. Spiteller, “Investigation of aldehydic lipid peroxidation products by gas chromatography-mass spectrometry,” Journal of Chromatography A, vol. 843, no. 1-2, pp. 29–98, 1999.
- A. Loidl-Stahlhofen and G. Spiteller, “α-Hydroxyaldehydes, products of lipid peroxidation,” Biochimica et Biophysica Acta, vol. 1211, no. 2, pp. 156–160, 1994.
- A. Mlakar and G. Spiteller, “Reinvestigation of lipid peroxidation of linolenic acid,” Biochimica et Biophysica Acta, vol. 1214, no. 2, pp. 209–220, 1994.
- A. Dudda, G. Spiteller, and F. Kobelt, “Lipid oxidation products in ischemic porcine heart tissue,” Chemistry and Physics of Lipids, vol. 82, no. 1, pp. 39–51, 1996.
- R. J. Kraemer and R. A. Deitrich, “Isolation and characterization of human liver aldehyde dehydrogenase,” Journal of Biological Chemistry, vol. 243, no. 24, pp. 6402–6408, 1968.
- N. Shangari, W. R. Bruce, R. Poon, and P. J. O'Brien, “Toxicity of glyoxals—role of oxidative stress, metabolic detoxification and thiamine deficiency,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1390–1393, 2003.
- A. Lapolla, R. Flamini, A. Dalla Vedova et al., “Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 9, pp. 1166–1173, 2003.
- E. N. Taylor and G. C. Curhan, “Determinants of 24-hour urinary oxalate excretion,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 5, pp. 1453–1460, 2008.
- B. H. Eisner, S. P. Porten, S. K. Bechis, and M. L. Stoller, “Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers,” Journal of Urology, vol. 183, no. 6, pp. 2244–2248, 2010.
- E. N. Taylor, M. J. Stampfer, and G. C. Curhan, “Diabetes mellitus and the risk of nephrolithiasis,” Kidney International, vol. 68, no. 3, pp. 1230–1235, 2005.
- H. S. Gill and G. A. Rose, “Mild metabolic hyperoxaluria and its response to pyridoxine,” Urologia Internationalis, vol. 41, no. 5, pp. 393–396, 1986.
- E. R. Yendt and M. Cohanim, “Clinical and laboratory approaches for evaluation of nephrolithiasis,” Journal of Urology, vol. 141, no. 3, pp. 764–769, 1989.
- G. A. Fishbein, R. G. Micheletti, J. S. Currier, E. Singer, and M. C. Fishbein, “Atherosclerotic oxalosis in coronary arteries,” Cardiovascular Pathology, vol. 17, no. 2, pp. 117–123, 2008.
- Y. Enoki, G. Katoh, H. Okabe, and A. Yanagisawa, “Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis,” Histopathology, vol. 56, no. 3, pp. 384–394, 2010.
- R. Katoh, A. Kawaoi, A. Muramatsu, A. Hemmi, and K. Suzuki, “Birefringent (calcium oxalate) crystals in thyroid diseases: a clinicopathological study with possible implications for differential diagnosis,” American Journal of Surgical Pathology, vol. 17, no. 7, pp. 698–705, 1993.
- J. T. Surratt, B. S. Monsees, and G. Mazoujian, “Calcium oxalate microcalcifications in the breast,” Radiology, vol. 181, no. 1, pp. 141–142, 1991.
- A. J. Chaplin, “Histopathological occurrence and characterisation of calcium oxalate: a review,” Journal of Clinical Pathology, vol. 30, no. 9, pp. 800–811, 1977.